Literature DB >> 5481521

Combined rifampicin and erythromycin for bacterial endocarditis.

M C Peard, D G Fleck, L P Garrod, P M Waterworth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5481521      PMCID： PMC1819992          DOI： 10.1136/bmj.4.5732.410

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  11 in total

Review 1.  Defence against bacterial drug resistance.

Authors:  L P Garrod
Journal:  Br Med J       Date:  1976-10-16

2.  Editorial: Mixed endocarditis in addicts.

Authors: 
Journal:  Br Med J       Date:  1974-07-20

3.  Coagulase-negative staphylococci causing endocarditis after cardiac surgery.

Authors:  D C Speller; R G Mitchell
Journal:  J Clin Pathol       Date:  1973-07       Impact factor: 3.411

4.  Oral antibiotic cure of staphylococcal endocarditis.

Authors:  N D Burman; C Watson; H S Joffe
Journal:  Postgrad Med J       Date:  1973-12       Impact factor: 2.401

5.  Pseudomonas cepacia endocarditis treated with co-trimoxazole and kanamycin.

Authors:  D C Speller
Journal:  Br Heart J       Date:  1973-01

6.  A case of Gemella morbillorum endocarditis.

Authors:  M J Martin; D A Wright; A R Jones
Journal:  Postgrad Med J       Date:  1995-03       Impact factor: 2.401

Review 7.  Rifampicin: a review.

Authors: 
Journal:  Drugs       Date:  1971       Impact factor: 9.546

8.  Combination of minocycline and rifampicin against methicillin- and gentamicin-resistant Staphylococcus aureus.

Authors:  E Yourassowsky; M P van der Linden; M J Lismont; F Crokaert
Journal:  J Clin Pathol       Date:  1981-05       Impact factor: 3.411

9.  Double-blind, placebo-controlled study of oxacillin combined with rifampin in the treatment of staphylococcal infections.

Authors:  P Van der Auwera; J Klastersky; J P Thys; F Meunier-Carpentier; J C Legrand
Journal:  Antimicrob Agents Chemother       Date:  1985-10       Impact factor: 5.191

10.  In vitro activity of rifampin alone and in combination with nafcillin and Vancomycin against pathogenic strains of Staphylococcus aureus.

Authors:  C U Tuazon; M Y Lin; J N Sheagren
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.